首页 | 本学科首页   官方微博 | 高级检索  
检索        

晚期非小细胞肺癌的维持治疗
引用本文:吕昆象,李文辉,侯宇,张明,王丽,奚江.晚期非小细胞肺癌的维持治疗[J].国际肿瘤学杂志,2014,41(4):283-285.
作者姓名:吕昆象  李文辉  侯宇  张明  王丽  奚江
作者单位:吕昆象 (650118,云南省肿瘤医院昆明医科大学第三附属医院放疗科); 李文辉 (650118,云南省肿瘤医院昆明医科大学第三附属医院放疗科); 侯宇 (650118,云南省肿瘤医院昆明医科大学第三附属医院放疗科); 张明 (650118,云南省肿瘤医院昆明医科大学第三附属医院放疗科); 王丽 (650118,云南省肿瘤医院昆明医科大学第三附属医院放疗科); 奚江 (650118,云南省肿瘤医院昆明医科大学第三附属医院放疗科);
摘    要:目前晚期非小细胞肺癌(NSCLC)一线治疗标准是以铂类为基础的双药化疗.标准疗程化疗后当疾病处于控制状态时下一步处理存在着很大争议,维持治疗逐渐应用于晚期NSCLC的治疗中.晚期NSCLC维持治疗可分为继续维持治疗与换药维持治疗,目前多用于维持治疗的培美曲塞和厄洛替尼已被证实可提高总体生存率.

关 键 词:  非小细胞肺  维持治疗  靶向治疗

Maintenance treatment of advanced non-small cell lung cancer
Lyu Kunxiang,Li Wenhui,Hou Yu,Zhang Ming,Wang Li,Xi Jiang.Maintenance treatment of advanced non-small cell lung cancer[J].Journal of International Oncology,2014,41(4):283-285.
Authors:Lyu Kunxiang  Li Wenhui  Hou Yu  Zhang Ming  Wang Li  Xi Jiang
Institution:. Department of Radiation Oncology, Third Affiliated Hospital of Kunming Medical University, Yunnan Tumor Hospital, Kunming 6.50118, China
Abstract:Currently platinum-based double chemotherapy is the standard first-line treatment for advanced non-small cell lung cancer ( NSCLC ). When the disease is under control, the next step after a stand- ard course of chemotherapy is controversial, and maintenance treatment is used in the treatment of advanced NSCLC increasingly. Maintenance treatment of advanced NSCLC includes continue maintenance treatment and medication changed maintenance therapy, currently used for maintenance therapy with pemetrexed and erlotinib are shown to improve overall survival, which are usually used for maintenance treatment.
Keywords:Carcinoma  non-small-cell lung  Maintenance treatment  Targeted therapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号